Cargando…
The efficacy and safety of sodium nitroprusside in the treatment of schizophrenia: Protocol for an updated systematic review and meta-analysis
BACKGROUND: Schizophrenia is a chronic persistent disease with high recurrence rate and high disability rate in the field of psychiatry. Sodium nitroprusside is a nitric oxide (NO) donor and considered a promising new compound for the treatment of schizophrenia. New high-quality clinical trials of s...
Autores principales: | Fei, Xinxing, Wang, Shiqi, Li, Jiyang, Wang, Jianxiong, Gao, Yaqian, Hu, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027216/ https://www.ncbi.nlm.nih.gov/pubmed/36940201 http://dx.doi.org/10.1371/journal.pone.0283185 |
Ejemplares similares
-
The efficacy and safety of sodium nitroprusside in the treatment of schizophrenia: a meta-analysis
por: Fei, Xinxing, et al.
Publicado: (2023) -
Safety and efficacy of intracoronary sodium nitroprusside for the assessment of coronary fractional flow reserve
por: Pedroni, Pablo, et al.
Publicado: (2018) -
Safety and Efficacy of Ginkgo-Damole and Nitroglycerin or Sodium Nitroprusside on Hypertensive Cerebropathies: A Meta-Analysis
por: Peng, Li, et al.
Publicado: (2020) -
The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial
por: Nazir, Sheraz A, et al.
Publicado: (2014) -
Sodium nitroprusside injection immediately before balloon inflation during percutaneous coronary intervention
por: Yu, Yan, et al.
Publicado: (2021)